End-of-day quote
Shanghai S.E.
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
24.13
CNY
|
-0.86%
|
|
+12.13%
|
+32.22%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,570
|
12,347
|
42,112
|
32,238
|
20,288
|
26,622
|
-
|
-
|
Enterprise Value (EV)
1 |
10,570
|
12,347
|
42,112
|
32,238
|
20,288
|
26,622
|
26,622
|
26,622
|
P/E ratio
|
31.2
x
|
18.4
x
|
9.92
x
|
5.57
x
|
15.6
x
|
14.2
x
|
11.5
x
|
10.3
x
|
Yield
|
0.97%
|
2.27%
|
1.32%
|
3.45%
|
3.29%
|
4.64%
|
3.63%
|
8.21%
|
Capitalization / Revenue
|
0.59
x
|
0.67
x
|
1.78
x
|
1.06
x
|
0.72
x
|
0.89
x
|
0.84
x
|
0.8
x
|
EV / Revenue
|
0.59
x
|
0.67
x
|
1.78
x
|
1.06
x
|
0.72
x
|
0.89
x
|
0.84
x
|
0.8
x
|
EV / EBITDA
|
7.3
x
|
6.59
x
|
5.92
x
|
3.25
x
|
5.32
x
|
5.55
x
|
5.15
x
|
4.62
x
|
EV / FCF
|
-
|
-
|
10.4
x
|
7.06
x
|
-21.1
x
|
9.08
x
|
5.54
x
|
5.63
x
|
FCF Yield
|
-
|
-
|
9.58%
|
14.2%
|
-4.73%
|
11%
|
18%
|
17.8%
|
Price to Book
|
1.3
x
|
1.31
x
|
3.05
x
|
1.6
x
|
0.99
x
|
1.2
x
|
1.1
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
1,028,233
|
1,119,393
|
1,111,725
|
1,111,671
|
1,111,675
|
1,103,254
|
-
|
-
|
Reference price
2 |
10.28
|
11.03
|
37.88
|
29.00
|
18.25
|
24.13
|
24.13
|
24.13
|
Announcement Date
|
28/04/20
|
11/04/21
|
04/03/22
|
20/03/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,039
|
18,317
|
23,607
|
30,311
|
28,105
|
30,004
|
31,674
|
33,484
|
EBITDA
1 |
1,448
|
1,873
|
7,117
|
9,905
|
3,810
|
4,799
|
5,165
|
5,758
|
EBIT
1 |
483.2
|
773.6
|
5,901
|
8,213
|
1,747
|
2,487
|
3,166
|
3,425
|
Operating Margin
|
2.68%
|
4.22%
|
25%
|
27.09%
|
6.22%
|
8.29%
|
9.99%
|
10.23%
|
Earnings before Tax (EBT)
1 |
456.5
|
706.6
|
5,390
|
7,871
|
1,716
|
2,420
|
3,077
|
3,320
|
Net income
1 |
302.5
|
623.9
|
4,247
|
5,852
|
1,379
|
1,878
|
2,331
|
2,600
|
Net margin
|
1.68%
|
3.41%
|
17.99%
|
19.31%
|
4.91%
|
6.26%
|
7.36%
|
7.77%
|
EPS
2 |
0.3300
|
0.6000
|
3.820
|
5.210
|
1.170
|
1.700
|
2.103
|
2.350
|
Free Cash Flow
1 |
-
|
-
|
4,035
|
4,566
|
-960.6
|
2,933
|
4,804
|
4,730
|
FCF margin
|
-
|
-
|
17.09%
|
15.06%
|
-3.42%
|
9.78%
|
15.17%
|
14.13%
|
FCF Conversion (EBITDA)
|
-
|
-
|
56.71%
|
46.09%
|
-
|
61.11%
|
93.01%
|
82.14%
|
FCF Conversion (Net income)
|
-
|
-
|
95.03%
|
78.02%
|
-
|
156.16%
|
206.11%
|
181.9%
|
Dividend per Share
2 |
0.1000
|
0.2500
|
0.5000
|
1.000
|
0.6000
|
1.120
|
0.8767
|
1.980
|
Announcement Date
|
28/04/20
|
11/04/21
|
04/03/22
|
20/03/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
4,035
|
4,566
|
-961
|
2,933
|
4,804
|
4,730
|
ROE (net income / shareholders' equity)
|
3.75%
|
7.31%
|
36.8%
|
34.8%
|
6.73%
|
8.3%
|
9.67%
|
10.4%
|
ROA (Net income/ Total Assets)
|
1.12%
|
2.16%
|
13.5%
|
14.9%
|
3.2%
|
3.9%
|
4.68%
|
5%
|
Assets
1 |
26,957
|
28,860
|
31,542
|
39,174
|
43,095
|
48,158
|
49,821
|
52,007
|
Book Value Per Share
2 |
7.920
|
8.450
|
12.40
|
18.10
|
18.50
|
20.10
|
22.00
|
22.60
|
Cash Flow per Share
2 |
1.010
|
2.150
|
4.800
|
6.190
|
1.310
|
4.100
|
4.630
|
3.760
|
Capex
1 |
1,054
|
851
|
1,302
|
2,318
|
2,414
|
2,421
|
2,136
|
1,196
|
Capex / Sales
|
5.84%
|
4.65%
|
5.51%
|
7.65%
|
8.59%
|
8.07%
|
6.74%
|
3.57%
|
Announcement Date
|
28/04/20
|
11/04/21
|
04/03/22
|
20/03/23
|
01/04/24
|
-
|
-
|
-
|
Last Close Price
24.13
CNY Average target price
24.91
CNY Spread / Average Target +3.24% Consensus |
1st Jan change
|
Capi.
|
---|
| +32.22% | 3.68B | | +5.86% | 105B | | -3.35% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|